Arcus Capital Partners, LLC Merck & Co., Inc. Transaction History
Arcus Capital Partners, LLC
- $248 Million
- Q2 2024
A detailed history of Arcus Capital Partners, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Arcus Capital Partners, LLC holds 1,635 shares of MRK stock, worth $183,250. This represents 0.08% of its overall portfolio holdings.
Number of Shares
1,635
Previous 1,742
6.14%
Holding current value
$183,250
Previous $229,000
11.79%
% of portfolio
0.08%
Previous 0.08%
Shares
4 transactions
Others Institutions Holding MRK
# of Institutions
3,829Shares Held
1.91BCall Options Held
13.4MPut Options Held
10.7M-
Vanguard Group Inc Valley Forge, PA245MShares$27.4 Billion0.59% of portfolio
-
Black Rock Inc. New York, NY207MShares$23.2 Billion0.59% of portfolio
-
State Street Corp Boston, MA117MShares$13.2 Billion0.65% of portfolio
-
Wellington Management Group LLP Boston, MA72.5MShares$8.12 Billion1.64% of portfolio
-
Geode Capital Management, LLC Boston, MA57MShares$6.39 Billion0.63% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $284B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...